Here,we report the development of covalent protein radiopharmaceuticalsthat leverage proximity-enabled reactivity to bind target irreversibly.We generated a radiolabeled covalent nanobody that bound the humanepidermal growth factor receptor 2 (HER2) irreversibly invitro and on cancer cell surfaces (Figure 1). Here, ERBB2 is linked to cancer.